Company Profile
AxoGen Stock Price, News & Catalysts
- Ticker:
- AXGN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
49.67 USD (+2.45%)
Close
Last updated: August 12, 2026
2.1B USD
Market cap
Why the stock is moving
As of Aug 12, 2026, AXGN closed up 2.45% at $49.67. No new same-company headline was identified in the current news window.
Company overview
Peripheral Nerve Repair Specialist
Axogen is a commercial-stage medical technology company focused on peripheral nerve regeneration and repair. Its products are used by surgeons to help restore nerve function after traumatic injuries or surgical procedures that damage motor or sensory nerves.
Core Surgical Product Portfolio
The company's portfolio includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. These products form a focused toolkit for nerve grafting, nerve protection, neuroma management, and soft tissue support.
Target Procedure Markets
Axogen's growth is concentrated across Extremities, Oral Maxillofacial and Head and Neck, and Breast. Management highlighted broad-based growth through the second quarter of 2026, supported by account productivity, expanding sales force coverage, and improving commercial insurance coverage and payment.
Evidence and Adoption Strategy
Axogen is investing in Level 1 evidence to support broader adoption. REPOSE evaluated Axoguard Nerve Cap for symptomatic neuroma management, while Nerve-RESTORE is comparing Avance Nerve Graft with sural nerve autograft in mixed and motor nerve reconstruction.
Future catalysts
- Future evidence from the Nerve-RESTORE randomized study comparing Avance Nerve Graft with sural nerve autograft in mixed and motor nerve reconstruction.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AxoGen (AXGN)?
AxoGen (AXGN) most recently closed at 49.67 USD, a +2.45% move versus the previous session.
What is the market cap of AxoGen (AXGN)?
AxoGen currently has a market capitalization of 2.1B USD on BioPharmSignal.
What does AxoGen do?
Peripheral Nerve Repair Specialist Axogen is a commercial-stage medical technology company focused on peripheral nerve regeneration and repair. Its products are used by surgeons to help restore nerve function after traumatic injuries or surgical procedures that damage motor or sensory nerves. Core Surgical Product Portfolio The company's portfolio includes...
On which exchange is AXGN stock listed?
AxoGen (AXGN) is associated with NASDAQ, United States, Biopharma.
What is Peripheral?
Peripheral Nerve Repair Specialist Axogen is a commercial-stage medical technology company focused on peripheral nerve regeneration and repair.
Which conditions is AxoGen targeting with Peripheral?
Peripheral Nerve Repair Specialist Axogen is a commercial-stage medical technology company focused on peripheral nerve regeneration and repair. Its products are used by surgeons to help restore nerve function after traumatic injuries or surgical procedures that damage motor or sensory nerves. Core Surgical Product Portfolio The company's portfolio includes...
How does AxoGen describe recent progress with Peripheral?
Future evidence from the Nerve-RESTORE randomized study comparing Avance Nerve Graft with sural nerve autograft in mixed and motor nerve reconstruction.
What is Nerve?
Peripheral Nerve Repair Specialist Axogen is a commercial-stage medical technology company focused on peripheral nerve regeneration and repair.